Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
Sponsor: Sanofi
Atopic Dermatitis
Italy
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Bulgaria, Chile, China +11 more
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Brazil, Bulgaria, Canada +9 more
- An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal PolypsActive Not Recruiting
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
United States, Australia, Canada, Chile, China +4 more
- A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareActive Not Recruiting
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Esophagitis (EoE)
United States
Sponsor: Sanofi
Rheumatoid Arthritis
United States
Sponsor: Yale University
Gaucher Disease
United States
- Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe AcneNot Yet Recruiting
Sponsor: Sanofi Pasteur, a Sanofi Company
Acne
Sponsor: Sanofi
RSV Immunization
Czechia
Sponsor: M.D. Anderson Cancer Center
Multiple Myeloma
United States
Sponsor: Sanofi
Dementia, Alzheimer's Type · Alzheimer's Disease
United States
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkActive Not Recruiting
Sponsor: Sanofi
Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Polyneuropathy, Inflammatory Demyelinating, Chronic
United States, Argentina, Belgium, Brazil, Bulgaria +19 more
Sponsor: Sanofi
Alopecia Areata
United States, Argentina, Australia, Bulgaria, Canada +11 more
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Belgium, Brazil +12 more
- A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsRecruiting
Sponsor: Blueprint Medicines Corporation
Advanced Solid Tumor · Non-Small Cell Lung Cancer · Colorectal Neoplasms · Pancreatic Ductal Adenocarcinoma
United States
Sponsor: University Hospital, Clermont-Ferrand
Knee Osteoarthritis (Knee OA)
France
Sponsor: Sanofi
Dermatitis Atopic
United States, Canada
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive Not Recruiting
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Crohn Disease · Colitis, Ulcerative
United States, Austria, Bulgaria, Czechia, Georgia +11 more
Sponsor: Sanofi
Atopic Dermatitis
United States, Canada, China, France, Italy +4 more
- Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: Sanofi
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Chile, Georgia +11 more
Sponsor: Sanofi
Chronic Spontaneous Urticaria
Argentina, Canada, Chile, Germany, Greece +8 more
- Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)Active Not Recruiting
Sponsor: Sanofi
Dermatitis Atopic
Argentina, Australia, Austria, Belgium, Colombia +17 more
Sponsor: Sanofi Pasteur, a Sanofi Company
Respiratory Syncytial Virus Immunization
United States, Australia, Puerto Rico
- A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)Active Not Recruiting
Sponsor: Cytokinetics
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
United States, Argentina, Australia, Brazil, Canada +15 more